Experience with emetine hydrochloride (NSC 33669) as an antitumor agent.

Panettiere, F

Experience with emetine hydrochloride (NSC 33669) as an antitumor agent. [electronic resource] - Cancer Apr 1971 - 835-41 p. digital

Publication Type: Journal Article

0008-543X

10.1002/1097-0142(197104)27:4<835::aid-cncr2820270413>3.0.co;2-k doi


Adenocarcinoma--drug therapy
Antineoplastic Agents--adverse effects
Breast Neoplasms--drug therapy
Carcinoma, Bronchogenic--drug therapy
Carcinoma, Squamous Cell--drug therapy
Carcinoma, Transitional Cell--drug therapy
Colonic Neoplasms--drug therapy
Diarrhea--chemically induced
Electrocardiography
Emetine--administration & dosage
Female
Humans
Injections, Intravenous
Laryngeal Neoplasms--drug therapy
Leukemia, Lymphoid--drug therapy
Lung Neoplasms--drug therapy
Lymphoma, Large B-Cell, Diffuse--drug therapy
Male
Melanoma--drug therapy
Myositis--chemically induced
Nausea--chemically induced
Tachycardia--chemically induced
Thyroid Neoplasms--drug therapy
Tracheal Neoplasms--drug therapy
Urinary Bladder Neoplasms--drug therapy